Version 5.4
Mus musculus Protein: Tra2b
Summary
InnateDB Protein IDBP-148075.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Tra2b
Protein Name transformer 2 beta homolog (Drosophila)
Synonyms 5730405G21Rik; D16Ertd266e; Sfrs10; SIG-41; Silg41; TRA2beta;
Species Mus musculus
Ensembl Protein ENSMUSP00000023564
InnateDB Gene IDBG-148073 (Tra2b)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 9 experimentally validated interaction(s) in this database.
They are also associated with 58 interaction(s) predicted by orthology.
Experimentally validated
Total 9 [view]
Protein-Protein 9 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 58 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0000166 nucleotide binding
GO:0003676 nucleic acid binding
GO:0003729 mRNA binding
Biological Process
GO:0000381 regulation of alternative mRNA splicing, via spliceosome
GO:0000398 mRNA splicing, via spliceosome
GO:0048026 positive regulation of mRNA splicing, via spliceosome
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID MGI:106016
InterPro IPR000504 RNA recognition motif domain
PFAM PF00076
PRINTS
PIRSF
SMART SM00360
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F8WJG3
UniProt Splice Variant
Entrez Gene 20462
UniGene Mm.431896
RefSeq XP_006521941
MGI ID
MGI Symbol Tra2b
OMIM
CCDS
HPRD
IMGT
EMBL AC154605 CT009567
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca